Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Ming-Yu Chou & Muh-Hwa Yang. (2021) Interplay of Immunometabolism and Epithelial–Mesenchymal Transition in the Tumor Microenvironment. International Journal of Molecular Sciences 22:18, pages 9878.
Crossref
Crossref
Jeroen Cremer, Sanne H. I. Hofstraat, Francoise van Heiningen, Irene K. Veldhuijzen, Birgit H. B. van Benthem & Kimberley S. M. Benschop. (2018) Genetic variation of hepatitis B surface antigen among acute and chronic hepatitis B virus infections in The Netherlands. Journal of Medical Virology 90:10, pages 1576-1585.
Crossref
Crossref
S. Louisirirotchanakul, K. Khupulsup, S. Akraekthalin, K.P. Chan, S. Saw, T.C. Aw, D.‐H. Cho, M.‐G. Shin & J. Lim. (2010) Comparison of the technical and clinical performance of the Elecsys® HBsAg II assay with the Architect®, AxSym®, and Advia® Centaur HBsAg screening assays. Journal of Medical Virology 82:5, pages 755-762.
Crossref
Crossref
Vincent Thibault, Syria Laperche, Sepideh Akhavan, Annabelle Servant-Delmas, Dalila Belkhiri & Anne-Marie Roque-Afonso. (2009) Impact of hepatitis B virus genotypes and surface antigen variants on the performance of HBV real time PCR quantification. Journal of Virological Methods 159:2, pages 265-270.
Crossref
Crossref
Alexandra Alexopoulou, Spyros P. Dourakis, Helen Pandelidaki, Athanasios J. Archimandritis & Peter Karayiannis. (2006) Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine. Journal of Medical Virology 78:8, pages 1043-1046.
Crossref
Crossref
Stephan Günther. (2006) Genetic variation in HBV infection: genotypes and mutants. Journal of Clinical Virology 36, pages S3-S11.
Crossref
Crossref
Mohammad Javad Kaviani. (2006) Occult hepatitis B virus infection and cryptogenic chronic hepatitis in an area with intermediate prevalence of HBV infection. World Journal of Gastroenterology 12:31, pages 5048.
Crossref
Crossref
Gerald Y. Minuk, Dong-feng Sun, Julia Uhanova, Manna Zhang, Shauna Caouette, Lindsay E. Nicolle, Adam Gutkin, Karen Doucette, Bruce Martin & Antonio Giulivi. (2005) Occult hepatitis B virus infection in a North American community-based population. Journal of Hepatology 42:4, pages 480-485.
Crossref
Crossref
Xuefeng Liu & Raymond F. Schinazi. 2003. Frontiers in Viral Hepatitis. Frontiers in Viral Hepatitis
15
33
.
CHONG JIN OON, WEI NING CHEN, KEE TAI GOH, STEVEN MESENAS, HAN SEONG NG, GILBERT CHIANG, CLARENCE TAN, SHIUAN KOH, SIAW WEI TENG, IVY TOH, MEI CHUNG MOH, KIAN SIM GOO, KAELING TAN, AI LIN LEONG & GEK SAN TAN. (2002) Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc. Journal of Gastroenterology and Hepatology 17, pages S491-S496.
Crossref
Crossref
Raymond C Chan. (2002) Hepatitis B virus surface gene variation: Just skin deep or profoundly pathogenic?. Journal of Gastroenterology and Hepatology 17:9, pages 933-934.
Crossref
Crossref
Henry Lik-Yuen Chan, Steven Woon-Choi Tsang, Nancy Wai-Yee Leung, Chi-Hang Tse, Yui Hui, John Siu-Lun Tam, Francis Ka-Leung Chan & Joseph Jao-Yiu Sung. (2002) Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. The American Journal of Gastroenterology 97:5, pages 1211-1215.
Crossref
Crossref
Hiroshi Yotsuyanagi, Kiyomi Yasuda, Kyoji Moriya, Yoshizumi Shintani, Hajime Fujie, Takeya Tsutsumi, Noriyoshi Nojiri, Takeo Juji, Hiromi Hoshino, Kazumi Shimoda, Kunihiko Hino, Satoshi Kimura, Shiro Iino & Kazuhiko Koike. (2002) Frequent presence of HBV in the sera of HBsAg‐negative, anti‐HBc‐positive blood donors. Transfusion 41:9, pages 1093-1099.
Crossref
Crossref
R.A. Heijtink, A.B. van Nunen, P. van Bergen, L. Östberg, A.D.M.E. Osterhaus & R.A. de Man. (2001) Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes. Journal of Medical Virology 64:4, pages 427-434.
Crossref
Crossref
Michael P. Cooreman, Geert Leroux-Roels & Wilma P. Paulij. (2001) Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. Journal of Biomedical Science 8:3, pages 237-247.
Crossref
Crossref
Apiradee Theamboonlers, Voranush Chongsrisawat, Pojchanad Jantaradsamee & Yong Poovorawan. (2001) Variants within the "a" Determinant of HBs Gene in Children and Adolescents with and without Hepatitis B Vaccination as Part of Thailand's Expanded Program on Immunization (EPI).. The Tohoku Journal of Experimental Medicine 193:3, pages 197-205.
Crossref
Crossref
Marcus Schories, Thomas Peters & Jens Rasenack. (2000) Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. Journal of Hepatology 33:5, pages 799-811.
Crossref
Crossref
Charles Hannoun, Peter Horal & Magnus Lindh. (2000) Long-term mutation rates in the hepatitis B virus genome. Microbiology 81:1, pages 75-83.
Crossref
Crossref
Hong-Yuan Hsu, Mei-Hwei Chang, Shwu-Huey Liaw, Yen-Hsuan Ni & Huey-Ling Chen. (1999) Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan. Hepatology 30:5, pages 1312-1317.
Crossref
Crossref
Michel P. Cooreman, Mark H. van Roosmalen, René te Morsche, Cécile M. G. Sünnen, Esther M. E. Schoondermark-van de Ven, Jan B. M. J. Jansen, Guido N. J. Tytgat, Pauline L. M. de Wit & Wilma P. Paulij. (1999) Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to g145r and other naturally occurring “a” loop escape mutations. Hepatology 30:5, pages 1287-1292.
Crossref
Crossref
Norio Ogata, Paul J. Cote, Alessandro R. Zanetti, Roger H. Miller, Max Shapiro, John Gerin & Robert H. Purcell. (1999) Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology 30:3, pages 779-786.
Crossref
Crossref
S. L. Ngui, R. Hallet & C. G. Teo. (1999) Natural and iatrogenic variation in hepatitis B virus. Reviews in Medical Virology 9:3, pages 183-209.
Crossref
Crossref
Francisco Rodriguez‐Frias, Maria Buti, Rosendo Jardi, Victor Vargas, Josep Quer, Montserrat Cotrina, Maria Martell, Rafael Esteban & Jaime Guardia. (2008) Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation. Liver 19:3, pages 177-182.
Crossref
Crossref
Chong Jin Oon, Wei Ning Chen, Yi Zhao, Siaw Wei Teng & Ai Lin Leong. (1999) Detection of hepatitis B surface antigen mutants and their integration in human hepatocellular carcinoma. Cancer Letters 136:1, pages 95-99.
Crossref
Crossref
Stephan Günther, Lutz Fischer, Irmgard Pult, Martina Sterneck & Hans Will. 1999.
25
137
.
C. ‐J. Oon & W. N. Chen. (2002) Current aspects of hepatitis B surface antigen mutants in Singapore. Journal of Viral Hepatitis 5:s2, pages 17-23.
Crossref
Crossref
Stefanie Grethe, Masyar Monazahian, Ingo Böhme & Reiner Thomssen. (1998) Characterization of Unusual Escape Variants of Hepatitis B Virus Isolated from a Hepatitis B Surface Antigen-Negative Subject. Journal of Virology 72:9, pages 7692-7696.
Crossref
Crossref
Mei-Shang Ho, Yi-Chien Mau, Chih-Feng Lu, Shiang-Fen Huang, Li-Ching Hsu, Sheue-Rong Lin & Hsu-Mei Hsu. (1998) Patterns of circulating hepatitis B surface antigen variants among vaccinated children born to hepatitis B surface antigen carrier and non-carrier mothers. Journal of Biomedical Science 5:5, pages 355-362.
Crossref
Crossref
Torre & Naoumov. (1998) Clinical implications of mutations in the hepatitis B virus genome. European Journal of Clinical Investigation 28:8, pages 604-614.
Crossref
Crossref
P. Maillard & J. Pillot. (1998) At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis. Research in Virology 149:3, pages 153-161.
Crossref
Crossref